This was not a task she relished
And they can achieve a slow, gradual weight loss, usually over the course of two years, potentially more, and then be seen for weight maintenance
Glucagon-like peptide-1 receptor agonist (GLP-1) medications have been used for glucose control in diabetic patients for several years
Until now the tests with exendin-4 had only been done in mice and the company was unsure what would happen when it was given to humans
Axford at I24, Diamond Light Source, Oxford, UK for technical support
Study design: Real-world data, real impact Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with AUD and either type 2 diabetes or obesity who started a GLP-1 RA to similar individuals starting alternative medications